Pulsed Field Ablation Market

Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share of Key Companies, Industry Trends and Global Forecasts, till 2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    62

  • Pages
    325

  • View Count
    7812

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1 Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1 Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market

3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk

3.2.4. Recession

3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Types of Ablation Techniques
5.3. Types of Catheter Ablation Techniques
5.3.1. Thermal Ablation Techniques
5.3.1.1. Radiofrequency Ablation
5.3.1.2. Laser Ablation
5.3.1.3. Microwave Ablation
5.3.1.4. Hydrothermal Ablation
5.3.1.5. High-Intensity Focused Ultrasound Ablation

5.3.2. Non-Thermal Ablation Techniques
5.3.2.1. Cryoablation
5.3.2.2. Mechanico-Chemical Ablation
5.3.2.3. Pulsed Field Ablation
5.4. Overview of Pulsed Field Ablation Therapy
5.4.1. Historical Evolution
5.4.2. Mechanism of Action
5.4.3. Therapeutic Applications
5.4.4. Advantages of Pulsed Field Ablation

5.5. Concluding Remarks

6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pulsed Field Ablation Devices: Overall Market Landscape
6.2.1. Analysis by Product Components
6.2.2. Analysis by Shape of Catheter
6.2.3. Analysis by Configuration of Catheter
6.2.4. Analysis by Type of Catheter (by Irrigation)
6.2.5. Analysis by Catheter Shaft Diameter
6.2.6. Analysis by Number of Electrodes
6.2.7. Analysis by Electrical Polarity
6.2.8. Analysis by Source of Ablation
6.2.9. Analysis by Status of Development
6.2.10. Analysis by Application Area
6.2.11. Analysis by Status of Development and Location of Clinical Trial
6.2.12. Analysis by Target Therapeutic Area and Target Indication
6.2.13. Analysis by Status of Development and Target Therapeutic Area
6.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
6.2.15 Analysis by Source of Ablation, Application Area, and Target Therapeutic Area

6.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters (Region)
6.3.5. Analysis by Type of Developer
6.3.6. Analysis by Company Ownership
6.3.7. Analysis by Company Ownership and Location of Headquarters (Region)

6.3.8. Most Active Players: Analysis by Number of Products

7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
7.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
7.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
7.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific

7.5. Concluding Remarks

8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
8.1. Chapter Overview
8.2. Boston Scientific
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Pulsed Field Ablation Portfolio
8.2.4. Recent Developments and Future Outlook

8.3. Medtronic
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Pulsed Field Ablation Portfolio
8.3.4. Recent Developments and Future Outlook

8.4. Galvanize Therapeutics
8.4.1. Company Overview
8.4.2. Pulsed Field Ablation Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Pulse Biosciences
8.5.1. Company Overview
8.5.2. Pulsed Field Ablation Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. AngioDynamics
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Pulsed Field Ablation Portfolio
8.6.4. Recent Developments and Future Outlook

8.7. Biosense Webster
8.7.1. Company Overview
8.7.2. Pulsed Field Ablation Portfolio
8.7.3. Recent Developments and Future Outlook

8.8. Acutus Medical
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Pulsed Field Ablation Portfolio
8.8.4. Recent Developments and Future Outlook

8.9. Kardium
8.9.1. Company Overview
8.9.2. Pulsed Field Ablation Portfolio
8.9.3. Recent Developments and Future Outlook

9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES
9.1. Chapter Overview
9.2. Abbott
9.3. AccuPulse Medical
9.4. Argá Medtech
9.5. AtriAN Medical
9.6. AuriGen Medical
9.7. CathRx
9.8. ElectroPhysiology Frontiers
9.9. EnChannel Medical
9.10. Hangzhou Dinova EP Technology

9.11. Mirai Medical
9.12. Tianjin Intelligent Health Medical

10. RECENT DEVELOPMENTS AND INITIATIVES
10.1 Chapter Overview
10.2 Partnerships and Collaborations

10.2.1. Partnership Models
10.2.2. Pulsed Field Ablation: Partnerships and Collaborations
10.2.3. Analysis by Year of Partnership
10.2.4. Analysis by Type of Partnership
10.2.5. Analysis by Year and Type of Partnership
10.2.6. Analysis by Type of Product
10.2.7. Analysis by Type of Partnership and Type of Solution
10.2.8. Analysis by Therapeutic Area
10.2.9. Analysis by Type of Partnership and Therapeutic Area
10.2.10. Most Active Players: Analysis by Number of Partnerships
10.2.11. Analysis by Geography
10.2.11.1. Intercontinental and Intracontinental Agreements
10.2.11.2. Local and International Agreements

10.3. Funding and Investments
10.3.1. Funding Models
10.3.2. Pulsed Field Ablation: Funding and Investments

10.3.3. Analysis by Year of Investment
10.3.3.1. Cumulative Year-wise Trend of Funding Instances
10.3.3.2. Cumulative Year-wise Trend of Amount Invested

10.3.4. Analysis by Type of Funding
10.3.4.1. Analysis of Funding Instances
10.3.4.2. Analysis of Amount Invested

10.3.5. Analysis by Year and Type of Funding
10.3.5.1. Analysis of Funding Instances
10.3.5.2. Analysis of Amount Invested

10.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
10.3.7. Most Active Players: Analysis by Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Funding Instances
10.3.10. Analysis of Funding Instances and Amount Invested by Geography

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Pulsed Field Ablation: Patent Analysis
11.3.1. Analysis by Patent Application Year
11.3.2. Analysis by Patent Publication Year
11.3.3. Analysis by Type of Patent and Patent Publication Year
11.3.4. Analysis by Publication Time
11.3.5. Analysis by Patent Jurisdiction
11.3.6. Analysis by CPC Symbols
11.3.7. Analysis by Type of Applicant
11.3.8. Analysis by Patent Age
11.3.9. Leading Players: Analysis by Number of Patents
11.3.10. Leading Patent Assignees: Analysis by Number of Patents

11.4. Pulsed Field Ablation: Patent Benchmarking Analysis
11.4.1. Analysis of Top CPC Codes by Leading Industry Players
11.4.2. Analysis of Top CPC Codes by Publication Time

11.5. Pulsed Field Ablation: Patent Valuation

12. GLOBAL EVENTS ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Global Events
12.3.1. Analysis by Year of Event
12.3.2. Analysis by Type of Event
12.3.3. Analysis by Year and Type of Event
12.3.4. Analysis by Event Platform
12.3.5. Analysis by Location of Event
12.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
12.3.7. Most Active Event Organizers: Analysis by Number of Events
12.3.8. Most Active Players: Analysis by Number of Events

12.4. Global Events: Speaker Analysis
12.4.1. Most Active Speakers: Analysis by Number of Events
12.4.2. Analysis by Designation of Speakers

12.5. Concluding Remarks

13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
13.1. Chapter Overview
13.2. Cardiac Mapping and Navigation Device Developers
13.2.1 Analysis by Year of Establishment
13.2.2 Analysis by Company Size
13.2.3 Analysis by Location of Headquarters

13.3. Likely Partner Analysis
13.3.1. Assumptions and Key Parameters
13.3.2. Methodology

13.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
13.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
13.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
13.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. GLOBAL PULSED FIELD ABLATION MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard

16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation
16.6.1. Insights from Secondary Research
16.6.2. Insights from In-house Repository
16.6.3. Dynamic Dashboard

17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Cardiovascular Disorders: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
17.4. Oncological Disorders: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Respiratory Disorders: Historical Trends (2020-2022) and Forecasted Estimates (2023-2035)
17.6. Dermatological Disorders: Historical Trends (2022) and Forecasted Estimates (2023-2035)
17.7. Data Triangulation
17.7.1. Insights from Secondary Research
17.7.2. Insights from In-house Repository
17.7.3. Dynamic Dashboard

18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
18.4. Generators: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation
18.5.1. Insights from Secondary Research
18.5.2. Insights from In-house Repository
18.5.3. Dynamic Dashboard

19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard

20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Ablation: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.4. Ablation and Mapping: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard

21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
21.4. Pulsed Field and Radiofrequency: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.5. Pulsed Field and Cryoablation: Historical Trends (2021-2022) and Future Estimates (2023-2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard

22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.1. US: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.3.2. Canada: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)

22.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.1. China: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
22.5.2. Japan: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)

22.6. Data Triangulation
22.6.1. Insights from Secondary Research
22.6.2. Insights from In-house Repository
22.6.3. Dynamic Dashboard

23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
23.6. Data Triangulation
23.6.1. Insights from Secondary Research
23.6.2. Insights from In-house Repository
23.6.3. Dynamic Dashboard

24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Catheters: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)

24.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
24.5. Data Triangulation
24.5.1. Insights from Secondary Research
24.5.2. Insights from In-house Repository
24.5.3. Dynamic Dashboard

25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Soft Tissue Ablative Cancers: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.4. Pancreatic Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.5. Prostate Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.6 Non-Small Cell Lung Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.7 Esophageal Cancer: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
25.8 Data Triangulation
25.8.1. Insights from Secondary Research
25.8.2 Insights from In-house Repository
25.8.3. Dynamic Dashboard

26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
26.1 Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. North America: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.4. Europe: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.5. Asia-Pacific: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
26.6. Data Triangulation
26.6.1. Insights from Secondary Research
26.6.2. Insights from In-house Repository
26.6.3. Dynamic Dashboard

27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
27.1 Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. Catheters : Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.4. Generators: Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)
27.5. Data Triangulation
27.5.1. Insights from Secondary Research
27.5.2. Insights from In-house Repository
27.5.3. Dynamic Dashboard

28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS 
28.1. Chapter Overview
28.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035)
28.3. Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035)
28.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035)
28.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035)

29. CONCLUDING REMARKS

30. APPENDIX 1: TABULATED DATA

31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 4.1 Executive Summary: Market Landscape
Figure 4.2 Executive Summary: Recent Developments and Initiatives
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Global Events Analysis
Figure 4.5 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Ablation Techniques
Figure 5.2 Steps Involved in Pulsed Field Ablation
Figure 5.3 Various Parameters related to Ablative Energy Delivery
Figure 5.4 Historical Evolution of Pulsed Field Ablation Therapy
Figure 5.5 Mechanism of Action: Steps of Irreversible Electroporation
Figure 5.6 Advantages of Pulsed Field Ablation
Figure 6.1 Pulsed Field Ablation Devices: Distribution by Product Components
Figure 6.2 Pulsed Field Ablation Devices: Distribution by Shape of Catheter
Figure 6.3 Pulsed Field Ablation Devices: Distribution by Configuration of Catheter
Figure 6.4 Pulsed Field Ablation Devices: Distribution by Type of Catheter (by Irrigation)
Figure 6.5 Pulsed Field Ablation Devices: Distribution by Catheter Shaft Diameter (in Fr)
Figure 6.6 Pulsed Field Ablation Devices: Distribution by Number of Electrodes
Figure 6.7 Pulsed Field Ablation Devices: Distribution by Electrical Polarity
Figure 6.8 Pulsed Field Ablation Devices: Distribution by Source of Ablation
Figure 6.9 Pulsed Field Ablation Devices: Distribution by Status of Development
Figure 6.10 Pulsed Field Ablation Devices: Distribution by Status of Development and Location of Clinical Trial
Figure 6.11 Pulsed Field Ablation Devices: Distribution by Application Area
Figure 6.12 Pulsed Field Ablation Devices: Distribution by Target Therapeutic Area and Target Indication
Figure 6.13 Pulsed Field Ablation Devices: Distribution by Status of Development and Target Therapeutic Area
Figure 6.14 Pulsed Field Ablation Devices: Distribution by Location of Clinical Trial and Target Therapeutic Area
Figure 6.15 Pulsed Field Ablation Devices: Distribution by Source of Ablation, Application Area and Target Therapeutic Area
Figure 6.16 Pulsed Field Ablation Device Developers: Distribution by Year of Establishment
Figure 6.17 Pulsed Field Ablation Device Developers: Distribution by Company Size
Figure 6.18 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Region)
Figure 6.19 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Country)
Figure 6.20 Pulsed Field Ablation Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Figure 6.21 Pulsed Field Ablation Device Developers: Distribution by Type of Developer
Figure 6.22 Pulsed Field Ablation Device Developers: Distribution by Company Ownership
Figure 6.23 Pulsed Field Ablation Device Developers: Distribution by Company Ownership and Location of Headquarters (Region)
Figure 6.24 Most Active Players: Distribution by Number of Products
Figure 7.1 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in North America
Figure 7.2 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Europe
Figure 7.3 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
Figure 7.4 Product Competitiveness Analysis of Pulsed Field Ablation Devices: Competitiveness Score of Top Products
Figure 8.1 Boston Scientific: Financial Information
Figure 8.2 Medtronic: Financial Information
Figure 8.3 AngioDynamics: Financial Information
Figure 8.4 Acutus Medical: Financial Information
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Pre-2019-2022
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 10.6 Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Partnership and Therapeutic Area
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.10 Partnerships and Collaborations: Local and International Agreements
Figure 10.11 Funding and Investments: Cumulative Year-wise Trend of Funding Instances, Pre-2016-2023
Figure 10.12 Funding and Investments: Cumulative Year-wise Trend of Amount Invested, Pre-2016-2023
Figure 10.13 Funding and Investments: Distribution of Funding Instances by Type of Funding
Figure 10.14 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 10.15 Funding and Investments: Distribution of Funding Instances by Year and Type of Funding
Figure 10.16 Funding and Investments: Distribution of Amount Invested by Year and Type of Funding (USD Million)
Figure 10.17 Funding and Investments: Distribution of Funding Instances and Amount Invested by Therapeutic Area
Figure 10.18 Most Active Players: Distribution by Funding Instances
Figure 10.19 Most Active Players: Distribution by Amount Raised
Figure 10.20 Leading Investors: Distribution by Funding Instances
Figure 10.21 Funding and Investments: Distribution of Funding Instances and Amount Invested by Geography
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Pre-2016-2023
Figure 11.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Figure 11.5 Patent Analysis: Distribution by Publication Time
Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction
Figure 11.7 Patent Analysis: Distribution by Type of Applicant
Figure 11.8 Patent Analysis: Distribution by Patent Age
Figure 11.9 Leading Players: Distribution by Number of Patents
Figure 11.10 Leading Patent Assignees: Distribution by Number of Patents
Figure 11.11 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) Leading Industry Players
Figure 11.12 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) by Publication Time
Figure 11.13 Pulsed Field Ablation Devices: Patent Valuation
Figure 12.1 Global Events Analysis: Cumulative Year-wise Trend, 2018-2023
Figure 12.2 Global Events Analysis: Distribution by Type of Event
Figure 12.3 Global Events Analysis: Distribution by Year and Type of Event
Figure 12.4 Global Events Analysis: Distribution by Event Platform
Figure 12.5 Global Events Analysis: Distribution by Location of Event (Region)
Figure 12.6 Global Events Analysis: Distribution by Location of Event (Country)
Figure 12.7 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Figure 12.8 Most Active Event Organizers: Distribution by Number of Events
Figure 12.9 Most Active Players: Distribution by Number of Events
Figure 12.10 Most Active Speakers: Distribution by Number of Events
Figure 12.11 Distribution by Designations of Speakers
Figure 13.1 Cardiac Mapping and Navigation Device Developers: Distribution by Year of Establishment
Figure 13.2 Cardiac Mapping and Navigation Device Developers: Distribution by Company Size
Figure 13.3 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Region)
Figure 13.4 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Country)
Figure 13.5 Cardiac Mapping and Navigation Device Developers: Likely Partners of Cardiac Pulsed Field Ablation Device Developers
Figure 15.1 Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Figure 15.2 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario I (USD Million)
Figure 15.3 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario II (USD Million)
Figure 15.4 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario III (USD Million)
Figure 15.5 Global Pulsed Field Ablation Market (Dynamic Dashboard Snippet)
Figure 16.1 Pulsed Field Ablation Market: Distribution by Geography, 2018, 2023 and 2035
Figure 16.2 Pulsed Field Ablation Market in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.3 Pulsed Field Ablation Market in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.4 Pulsed Field Ablation Market in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.5 Pulsed Field Ablation Market: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 17.1 Pulsed Field Ablation Market: Distribution by Therapeutic Area, 2018, 2023 and 2035
Figure 17.2 Pulsed Field Ablation Market for Cardiovascular Disorders, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.3 Pulsed Field Ablation Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.4 Pulsed Field Ablation Market for Respiratory Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.5 Pulsed Field Ablation Market for Dermatological Disorders, Historical Trends (2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.6 Pulsed Field Ablation Market: Distribution by Therapeutic Area (Dynamic Dashboard Snippet)
Figure 18.1 Pulsed Field Ablation Market: Distribution by Product Components, 2018, 2023 and 2035
Figure 18.2 Pulsed Field Ablation Market for Catheters, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.3 Pulsed Field Ablation Market for Generators, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.4 Pulsed Field Ablation Market: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 19.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components, 2021, 2023 and 2035
Figure 19.2 Pulsed Field Ablation Market for Cardiovascular Disorders using Catheters, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.3 Pulsed Field Ablation Market for Cardiovascular Disorders using Generators, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.4 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 20.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area, 2021, 2023 and 2035
Figure 20.2 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USDMillion)
Figure 20.3 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation and Mapping Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.4 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area (Dynamic Dashboard Snippet)
Figure 21.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation, 2021, 2023 and 2035
Figure 21.2 Pulsed Field Ablation Market for Cardiovascular Disorders using PF Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 21.3 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and RF Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 21.4 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and Cryo Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates(2023-2035) (USD Million)
Figure 21.5 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation (Dynamic Dashboard Snippet)
Figure 22.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Geography, 2021, 2023 and 2035
Figure 22.2 Pulsed Field Ablation Market for Cardiovascular Disorders in North America, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.3 Pulsed Field Ablation Market for Cardiovascular Disorders in US, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.4 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.5 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates(2023-2035) (USD Million)
Figure 22.6 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.7 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.8 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.9 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.10 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.11 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.12 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.13 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.14 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.15 Pulsed Field Ablation Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.16 Pulsed Field Ablation Market for Cardiovascular Disorders in China, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.17 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.18 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.19 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.20 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.21 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.22 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.23 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 22.24 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Region (Dynamic Dashboard Snippet)
Figure 23.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography, 2018, 2023 and 2035
Figure 23.2 Pulsed Field Ablation Market for Oncological Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 23.3 Pulsed Field Ablation Market for Oncological Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 23.4 Pulsed Field Ablation Market for Oncological Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 23.5 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 24.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components, 2018, 2023 and 2035
Figure 24.2 Pulsed Field Ablation Market for Oncological Disorders using Catheters, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 24.3 Pulsed Field Ablation Market for Oncological Disorders using Generators, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 24.4 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 25.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer, 2018, 2023 and 2035
Figure 25.2 Pulsed Field Ablation Market for Soft-tissue Ablative Cancers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 25.3 Pulsed Field Ablation Market for Pancreatic Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 25.4 Pulsed Field Ablation Market for Prostate Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 25.5 Pulsed Field Ablation Market for Non-Small Cell Lung Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 25.6 Pulsed Field Ablation Market for Esophageal Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 25.7 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer (Dynamic Dashboard Snippet)
Figure 26.1 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography, 2020, 2023 and 2035
Figure 26.2 Pulsed Field Ablation Market for Respiratory Disorders in North America, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 26.3 Pulsed Field Ablation Market for Respiratory Disorders in Europe, Historical Trends (2020-2022) and Foreca sted Estimates (2023-2035) (USD Million)
Figure 26.4 Pulsed Field Ablation Market for Respiratory Disorders in Asia-Pacific, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 26.5 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 27.1 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components, 2019, 2023 and 2035
Figure 27.2 Pulsed Field Ablation Market for Respiratory Disorders using Catheters, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 27.3 Pulsed Field Ablation Market for Respiratory Disorders using Generators, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 27.4 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 28.1 Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Figure 28.2 Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Figure 28.3 Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Figure 28.4 AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Figure 29.1 Concluding Remarks: Overall Market Landscape
Figure 29.2 Concluding Remarks: Recent Developments
Figure 29.3 Concluding Remarks: Patent Analysis
Figure 29.4 Concluding Remarks: Global Events Analysis
Figure 29.5 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 5.1 Differences between Catheter Ablation and Surgical Ablation
Table 5.2 Types of Catheter Ablation Techniques: Information on Mechanism of Action, Advantages and Disadvantages
Table 6.1 List of Pulsed Field Ablation Devices
Table 6.2 Pulsed Field Ablation Devices: Information on Shape of Catheter, Configuration of Catheter and Type of Catheter (by Irrigation)
Table 6.3 Pulsed Field Ablation Devices: Information on Catheter Shaft Diameter, Number of Electrodes and Electrical Polarity
Table 6.4 Pulsed Field Ablation Devices: Information on Source of Ablation, Status of Development, Phase of Development of Investigational Devices and Application Area
Table 6.5 Pulsed Field Ablation Devices: Information on NCT Number and Location of Clinical Trial
Table 6.6 Pulsed Field Ablation Devices: Information on Target Indication and Target Therapeutic Area
Table 6.7 List of Pulsed Field Ablation Device Developers
Table 8.1 Leading Developers of Pulsed Field Ablation Systems
Table 8.2 Boston Scientific: Company Snapshot
Table 8.3 Boston Scientific: Pulsed Field Ablation Portfolio
Table 8.4 Boston Scientific: Recent Developments and Future Outlook
Table 8.5 Medtronic: Company Snapshot
Table 8.6 Medtronic: Pulsed Field Ablation Portfolio
Table 8.7 Medtronic: Recent Developments and Future Outlook
Table 8.8 Galvanize Therapeutics: Company Snapshot
Table 8.9 Galvanize Therapeutics: Pulsed Field Ablation Portfolio
Table 8.10 Galvanize Therapeutics: Recent Developments and Future Outlook
Table 8.11 Pulse Biosciences: Company Snapshot
Table 8.12 Pulse Biosciences: Pulsed Field Ablation Portfolio
Table 8.13 Pulse Biosciences: Recent Developments and Future Outlook
Table 8.14 AngioDynamics: Company Snapshot
Table 8.15 AngioDynamics: Pulsed Field Ablation Portfolio
Table 8.16 AngioDynamics: Recent Developments and Future Outlook
Table 8.17 Biosense Webster: Company Snapshot
Table 8.18 Biosense Webster: Pulsed Field Ablation Portfolio
Table 8.19 Biosense Webster: Recent Developments and Future Outlook
Table 8.20 Acutus Medical: Company Snapshot
Table 8.21 Acutus Medical: Pulsed Field Ablation Portfolio
Table 8.22 Acutus Medical: Recent Developments and Future Outlook
Table 8.23 Kardium: Company Snapshot
Table 8.24 Kardium: Pulsed Field Ablation Portfolio
Table 8.25 Kardium: Recent Developments and Future Outlook
Table 9.1 Abbott: Company Snapshot and Product Portfolio
Table 9.2 AccuPulse Medical: Company Snapshot and Product Portfolio
Table 9.3 Argá Medtech: Company Snapshot and Product Portfolio
Table 9.4 AtriAN Medical: Company Snapshot and Product Portfolio
Table 9.5 AuriGen Medical: Company Snapshot and Product Portfolio
Table 9.6 CathRx: Company Snapshot and Product Portfolio
Table 9.7 ElectroPhysiology Frontiers: Company Snapshot and Product Portfolio
Table 9.8 EnChannel Medical: Company Snapshot and Product Portfolio
Table 9.9 Hangzhou Dinova EP Technology: Company Snapshot and Product Portfolio
Table 9.10 Mirai Medical: Company Snapshot and Product Portfolio
Table 9.11 Tianjin Intelligent Health Medical: Company Snapshot and Product Portfolio
Table 10.1 Pulsed Field Ablation: List of Partnerships and Collaborations
Table 10.2 Pulsed Field Ablation: List of Funding and Investments
Table 11.1 Patent Analysis: Top CPC Sections
Table 11.2 Patent Analysis: Top CPC Symbols
Table 11.3 Patent Analysis: Top CPC Codes
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Analysis: List of Leading Patents (by Number of Citations)
Table 12.1 Pulsed Field Ablation: List of Global Events
Table 13.1 List of Cardiac Mapping and Navigation Device Developers
Table 13.2 Likely Partner Analysis: Cardiac Mapping and Navigation Device Developers
Table 30.1 Pulsed Field Ablation Devices: Distribution by Product Components
Table 30.2 Pulsed Field Ablation Devices: Distribution by Shape of Catheter
Table 30.3 Pulsed Field Ablation Devices: Distribution by Configuration of Catheter
Table 30.4 Pulsed Field Ablation Devices: Distribution by Type of Catheter (by Irrigation)
Table 30.5 Pulsed Field Ablation Devices: Distribution by Catheter Shaft Diameter (in Fr)
Table 30.6 Pulsed Field Ablation Devices: Distribution by Number of Electrodes
Table 30.7 Pulsed Field Ablation Devices: Distribution by Electrical Polarity
Table 30.8 Pulsed Field Ablation Devices: Distribution by Source of Ablation
Table 30.9 Pulsed Field Ablation Devices: Distribution by Status of Development
Table 30.10 Pulsed Field Ablation Devices: Distribution by Status of Development and Location of Clinical Trial
Table 30.11 Pulsed Field Ablation Devices: Distribution by Application Area
Table 30.12 Pulsed Field Ablation Devices: Distribution by Target Therapeutic Area and Target Indication
Table 30.13 Pulsed Field Ablation Devices: Distribution by Status of Development and Target Therapeutic Area
Table 30.14 Pulsed Field Ablation Devices: Distribution by Location of Clinical Trial and Target Therapeutic Area
Table 30.15 Pulsed Field Ablation Devices: Distribution by Source of Ablation, Application Area and Target Therapeutic Area
Table 30.16 Pulsed Field Ablation Device Developers: Distribution by Year of Establishment
Table 30.17 Pulsed Field Ablation Device Developers: Distribution by Company Size
Table 30.18 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Region)
Table 30.19 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Country)
Table 30.20 Pulsed Field Ablation Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Table 30.21 Pulsed Field Ablation Device Developers: Distribution by Type of Developer
Table 30.22 Pulsed Field Ablation Device Developers: Distribution by Company Ownership
Table 30.23 Pulsed Field Ablation Device Developers: Distribution by Company Ownership and Location of Headquarters (Region)
Table 30.24 Most Active Players: Distribution by Number of Products
Table 30.25 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in North America
Table 30.26 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Europe
Table 30.27 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
Table 30.28 Product Competitiveness Analysis of Pulsed Field Ablation Devices: Competitiveness Score of Top Products
Table 30.29 Boston Scientific: Financial Information
Table 30.30 Medtronic: Financial Information
Table 30.31 AngioDynamics: Financial Information
Table 30.32 Acutus Medical: Financial Information
Table 30.33 Partnerships and Collaborations: Cumulative Year-wise Trend, Pre-2019-2022
Table 30.34 Partnerships and Collaborations: Distribution by Type of Partnership
Table 30.35 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 30.36 Partnerships and Collaborations: Distribution by Type of Product
Table 30.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 30.38 Partnerships and Collaborations: Distribution by Therapeutic Area
Table 30.39 Partnerships and Collaborations: Distribution by Type of Partnership and Therapeutic Area
Table 30.40 Most Active Players: Distribution by Number of Partnerships
Table 30.41 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 30.42 Partnerships and Collaborations: Local and International Agreements
Table 30.43 Funding and Investments: Cumulative Year-wise Trend of Funding Instances, Pre-2016-2023
Table 30.44 Funding and Investments: Cumulative Year-wise Trend of Amount Invested, Pre-2016-2023
Table 30.45 Funding and Investments: Distribution of Funding Instances by Type of Funding
Table 30.46 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Table 30.47 Funding and Investments: Distribution of Funding Instances by Year and Type of Funding
Table 30.48 Funding and Investments: Distribution of Amount Invested by Year and Type of Funding (USD Million)
Table 30.49 Funding and Investments: Distribution of Funding Instances and Amount Invested by Therapeutic Area
Table 30.50 Most Active Players: Distribution by Funding Instances
Table 30.51 Most Active Players: Distribution by Amount Raised
Table 30.52 Leading Investors: Distribution by Funding Instances
Table 30.53 Funding and Investments: Distribution of Funding Instances and Amount Invested by Geography
Table 30.54 Patent Analysis: Distribution by Type of Patent
Table 30.55 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Table 30.56 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Pre-2016-2023
Table 30.57 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Table 30.58 Patent Analysis: Distribution by Publication Time
Table 30.59 Patent Analysis: Distribution by Patent Jurisdiction
Table 30.60 Patent Analysis: Distribution by Type of Applicant
Table 30.61 Patent Analysis: Distribution by Patent Age
Table 30.62 Leading Players: Distribution by Number of Patents
Table 30.63 Leading Patent Assignees: Distribution by Number of Patents
Table 30.64 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Table 30.65 Patent Benchmarking Analysis: Distribution of Publication Time by Patent Characteristics (CPC Codes)
Table 30.66 Pulsed Field Ablation: Patent Valuation
Table 30.67 Global Events Analysis: Cumulative Year-wise Trend, 2018-2023
Table 30.68 Global Events Analysis: Distribution by Type of Event
Table 30.69 Global Events Analysis: Distribution by Year and Type of Event
Table 30.70 Global Events Analysis: Distribution by Event Platform
Table 30.71 Global Events Analysis: Distribution by Location of Event (Region)
Table 30.72 Global Events Analysis: Distribution by Location of Event (Country)
Table 30.73 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Table 30.74 Most Active Event Organizers: Distribution by Number of Events
Table 30.75 Most Active Participants: Distribution by Number of Events
Table 30.76 Most Active Speakers: Distribution by Number of Events
Table 30.77 Distribution by Designations of Speakers
Table 30.78 Cardiac Mapping and Navigation Device Developers: Distribution by Year of Establishment
Table 30.79 Cardiac Mapping and Navigation Device Developers: Distribution by Company Size
Table 30.80 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Region)
Table 30.81 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Country)
Table 30.82 Cardiac Mapping and Navigation Device Developers: Likely Partners of Cardiac Pulsed Field Ablation Device Developers
Table 30.83 Global Pulsed Field Ablation Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Table 30.84 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario I (USD Million)
Table 30.85 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario II (USD Million)
Table 30.86 Global Pulsed Field Ablation Market, Forecasted Estimates (2023-2035), Scenario III (USD Million)
Table 30.87 Pulsed Field Ablation Market: Distribution by Geography, 2018, 2023 and 2035
Table 30.88 Pulsed Field Ablation Market in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.89 Pulsed Field Ablation Market in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.90 Pulsed Field Ablation Market in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.91 Pulsed Field Ablation Market: Distribution by Therapeutic Area, 2018, 2023 and 2035
Table 30.92 Pulsed Field Ablation Market for Cardiovascular Disorders, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.93 Pulsed Field Ablation Market for Oncological Disorders, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.94 Pulsed Field Ablation Market for Respiratory Disorders, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.95 Pulsed Field Ablation Market for Dermatological Disorders, Historical Trends (2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.96 Pulsed Field Ablation Market: Distribution by Product Components, 2018, 2023 and 2035
Table 30.97 Pulsed Field Ablation Market for Catheters, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.98 Pulsed Field Ablation Market for Generators, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.99 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components, 2021, 2023 and 2035
Table 30.100 Pulsed Field Ablation Market for Cardiovascular Disorders using Catheters, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.101 Pulsed Field Ablation Market for Cardiovascular Disorders using Generators, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.102 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area, 2021, 2023 and 2035
Table 30.103 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.104 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation and Mapping Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USDMillion)
Table 30.105 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation, 2021, 2023 and 2035
Table 30.106 Pulsed Field Ablation Market for Cardiovascular Disorders using PF Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)(USD Million)
Table 30.107 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and RF Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates (202-32035)(USD Million)
Table 30.108 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and Cryo Energy-based Devices, Historical Trends (2021-2022) and Forecasted Estimates (223-2035)(USD Million)
Table 30.109 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Geography, 2021, 2023 and 2035
Table 30.110 Pulsed Field Ablation Market for Cardiovascular Disorders in North America, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.111 Pulsed Field Ablation Market for Cardiovascular Disorders in US, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.112 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates(-20232035) (USD Million)
Table 30.113 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035)(USD Million)
Table 30.114 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates(-20232035) (USD Million)
Table 30.115 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.116 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (223-2035) (USD Million)
Table 30.117 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates(20244987035) (USD Million)
Table 30.118 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (20-232035) (USD Million)
Table 30.119 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.120 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates (20-232035) (USD Million)
Table 30.121 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates(2023-2035) (USD Million)
Table 30.122 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates (20-232035) (USD Million)
Table 30.123 Pulsed Field Ablation Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.124 Pulsed Field Ablation Market for Cardiovascular Disorders in China, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.125 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates(20244987035) (USD Million)
Table 30.126 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates(-20232035) (USD Million)
Table 30.127 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates(20244987035) (USD Million)
Table 30.128 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan, Historical Trends (2021-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.129 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Product Components, Historical Trends (2021-2022) and Forecasted Estimates(20244987035) (USD Million)
Table 30.130 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Application Area, Historical Trends (2021-2022) and Forecasted Estimates(-20232035) (USD Million)
Table 30.131 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Source of Ablation, Historical Trends (2021-2022) and Forecasted Estimates(20244987035) (USD Million)
Table 30.132 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography, 2018, 2023 and 2035
Table 30.133 Pulsed Field Ablation Market for Oncological Disorders in North America, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.134 Pulsed Field Ablation Market for Oncological Disorders in Europe, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.135 Pulsed Field Ablation Market for Oncological Disorders in Asia-Pacific, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.136 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components, 2018, 2023 and 2035
Table 30.137 Pulsed Field Ablation Market for Oncological Disorders using Catheters, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.138 Pulsed Field Ablation Market for Oncological Disorders using Generators, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.139 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer, 2018, 2023 and 2035
Table 30.140 Pulsed Field Ablation Market for Soft-tissue Ablative Cancers, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.141 Pulsed Field Ablation Market for Pancreatic Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.142 Pulsed Field Ablation Market for Prostate Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.143 Pulsed Field Ablation Market for Non-Small Cell Lung Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.144 Pulsed Field Ablation Market for Esophageal Cancer, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.145 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography, 2020, 2023 and 2035
Table 30.146 Pulsed Field Ablation Market for Respiratory Disorders in North America, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.147 Pulsed Field Ablation Market for Respiratory Disorders in Europe, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.148 Pulsed Field Ablation Market for Respiratory Disorders in Asia-Pacific, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.149 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components, 2019, 2023 and 2035
Table 30.150 Pulsed Field Ablation Market for Respiratory Disorders using Catheters, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.151 Pulsed Field Ablation Market for Respiratory Disorders using Generators, Historical Trends (2020-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 30.152 Boston Scientific: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Table 30.153 Medtronic: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Table 30.154 Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)
Table 30.155 AngioDynamics: Pulsed Field Ablation Sales Forecast (2023-2035) (USD Million)

List Of Companies

  1. Abbott
  2. AccuPulse Medical
  3. Acutus Medical
  4. Adagio Medical
  5. Affera
  6. Analog Devices
  7. AngioDynamics
  8. APN Health
  9. Argá Medtech
  10. AtriAN Medical
  11. AuriGen Medical
  12. Biosense Webster
  13. BioSig Technologies
  14. BIOTRONIK
  15. Boston Scientific
  16. Cardiac Designs
  17. CardioFocus
  18. CardioNXT
  19. Catheter Precision
  20. CathRx
  21. Chongqing University 
  22. Coherex Medical (Acquired by Biosense Webster)
  23. CoreMap
  24. Corify Care
  25. CRC EP
  26. ElectroPhysiology Frontiers
  27. EnChannel Medical
  28. EP Map-System
  29. FARAPULSE
  30. Field Medical
  31. Gala Therapeutics
  32. Galaxy Medical
  33. Galvanize Therapeutics
  34. Gradient Medical
  35. Hangzhou Dinova EP Technology
  36. Hangzhou Ruidi Biotechnology
  37. Innovative Health
  38. Japan Lifeline
  39. Kardium
  40. Medtronic
  41. MicroPort
  42. Minnetronix Medical
  43. Mirai Medical
  44. Ningbo No. 1 Hospital
  45. Peerbridge Health
  46. Philips
  47. Pulse Biosciences
  48. RBC Medical Innovations
  49. Remedicine
  50. Rhythm AI
  51. Rhythm Xience (Acquired by Acutus Medical)
  52. Shanghai Changhai Hospita
  53. Shanghai Xuanyu Medical Equipment
  54. Sichuan Jinjiang Electronic Medical Device Technology-JJET
  55. Sirona Medical 
  56. St. Paul’s Hospital
  57. Suzhou Aikemai Medical Technology
  58. Tianjin Intelligent Health Medical
  59. University of Wisconsin-Madison
  60. Utrecht University
  61. Zhejiang Jiashi Shangyang Medical Technology
  62. Zhouling Medical Applianc

Source 1: https://www.mayoclinic.org/tests-procedures/ablation-therapy/about/pac-20385072
Source 2: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.316340

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com